Investigation of the use of a genetic-led approach for the management of multiple medications in the ageing populatio
- Conditions
- Patients on three or more medications for cardiovascular disease, mental health, pain and gastroprotectionNot Applicable
- Registration Number
- ISRCTN99830995
- Lead Sponsor
- Congenica Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 480
1. Over 50 years of age
2. Taking three or more medications for cardiovascular health, pain (musculoskeletal), gastroprotection and mental health
3. Agree to follow up after pharmacogenomic analysis
1. Do not have the capacity to consent to take part in the project
2. Suffering from terminal cancer or terminal disease
3. Pregnant
4. Suffering from severe mental illness
5. Under the age of 50 years
6. Are not able to understand English or translated material
7. Do not agree to follow up after pharmacogenomic analysis and in particular those patients who have actionable pharmacogenomic data
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method